Pulmonary embolism prophylaxis in more than 30,000 total knee arthroplasty patients: Is there a best choice?

Journal of Arthroplasty

Volumn 27, Issue 2, 2012, Pages 167-172

  Khatod, Monti ^a   Inacio, Maria C S ^a   Bini, Stefano A ^b   Paxton, Elizabeth W ^a  

^a KAISER PERMANENTE   (United States)

^b KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

Knee arthroplasty; Prophylaxis; Pulmonary embolism; Registry

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

AGE; AGED; ANESTHESIA; ARTICLE; CONTROLLED STUDY; DEATH; DISEASE REGISTRY; FEMALE; GENERAL ANESTHESIA; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; SCORING SYSTEM; THROMBOSIS PREVENTION; TOTAL KNEE REPLACEMENT; VENOUS THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, KNEE; ASPIRIN; CALIFORNIA; COHORT STUDIES; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MIDDLE AGED; MOTION THERAPY, CONTINUOUS PASSIVE; MULTIVARIATE ANALYSIS; PREVALENCE; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; REGISTRIES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; WARFARIN; YOUNG ADULT;

EID: 84855557690     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2011.04.006     Document Type: Article

References (22)

1. Harris W.H., Sledge C.B. Total hip and total knee replacement (2). N Engl J Med 1990, 323:801.
2. Liang M.H., Cullen K.E., Larson M.G., et al. Cost-effectiveness of total joint arthroplasty in osteoarthritis. Arthritis Rheum 1986, 29:937.
3. Geerts W.H., Bergqvist D., Pineo G.F., et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008, 133:381S.
4. Geerts W.H., Pineo G.F., Heit J.A., et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004, 126:338S.
5. Eikelboom J.W., Karthikeyan G., Fagel N., et al. American Association of Orthopedic Surgeons and American College of Chest Physicians guidelines for venous thromboembolism prevention in hip and knee arthroplasty differ: what are the implications for clinicians and patients?. Chest 2009, 135:513.
6. Guideline on the Prevention of Symptomatic Pulmonary Embolism in Patients Undergoing Total Hip or Knee Arthroplasty. 2007. (Accessed November 30th, 2009, at). http://www.aaos.org/research/guidelines/PEguide.asp.
7. NIH Consensus Statement on total knee replacement December 8-10, 2003. J Bone Joint Surg Am 2004, 86-A:1328.
8. Specifications Manual for National Hospital Inpatient Quality Measures Discharges 04-01-09 (2Q09) through 09-30-09 (Q309) which is Section 2.4. Center for Medicare and Medicaid Service and The Joint Commission, 2009.(Accessed November 30th, 2009, at). http://www.jointcommission.org/PerformanceMeasurement/PerformanceMeasurement/Current.
9. Paxton E.W., Inacio M.C., Khatod M., et al. Kaiser Permanente National Total Joint Replacement Registry: aligning operations with information technology. Clin Orthop Relat Res 2010, 468:2646.
10. AHRQ Agency for healthcare research and quality, quality indicators. Patient safety indicators download 2007.
11. Henderson K.E., Recktenwald A., Reichley R.M., et al. Clinical validation of the AHRQ postoperative venous thromboembolism patient safety indicator. Jt Comm J Qual Patient Saf 2009, 35:370.
12. Zhan C., Battles J., Chiang Y.P., et al. The validity of ICD-9-CM codes in identifying postoperative deep vein thrombosis and pulmonary embolism. Jt Comm J Qual Patient Saf 2007, 33:326.
13. Khatod M., Inacio M., Paxton E.W., et al. Knee replacement: epidemiology, outcomes, and trends in Southern California: 17,080 replacements from 1995 through 2004. Acta Orthop 2008, 79:812.
14. Hodge W.A. Prevention of deep vein thrombosis after total knee arthroplasty. Coumadin versus pneumatic calf compression. Clin Orthop Relat Res 1991, 101.
15. Haas S.B., Insall J.N., Scuderi G.R., et al. Pneumatic sequential-compression boots compared with aspirin prophylaxis of deep-vein thrombosis after total knee arthroplasty. J Bone Joint Surg Am 1990, 72:27.
16. Westrich G.H., Bottner F., Windsor R.E., et al. VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty. J Arthroplasty 2006, 21:139.
17. Hooker J.A., Lachiewicz P.F., Kelley S.S. Efficacy of prophylaxis against thromboembolism with intermittent pneumatic compression after primary and revision total hip arthroplasty. J Bone Joint Surg Am 1999, 81:690.
18. Lachiewicz P.F., Soileau E.S. Multimodal prophylaxis for THA with mechanical compression. Clin Orthop Relat Res 2006, 453:225.
19. Lieberman J.R., Huo M.M., Hanway J., et al. The prevalence of deep venous thrombosis after total hip arthroplasty with hypotensive epidural anesthesia. J Bone Joint Surg Am 1994, 76:341.
20. Westrich G.H., Sculco T.P. Prophylaxis against deep venous thrombosis after total knee arthroplasty. Pneumatic plantar compression and aspirin compared with aspirin alone. J Bone Joint Surg Am 1996, 78:826.
21. Hawker G.A., Coyte P.C., Wright J.G., et al. Accuracy of administrative data for assessing outcomes after knee replacement surgery. J Clin Epidemiol 1997, 50:265.
22. Burnett R.S., Clohisy J.C., Wright R.W., et al. Failure of the American College of Chest Physicians-1A protocol for Lovenox in clinical outcomes for thromboembolic prophylaxis. J Arthroplasty 2007, 22:317.